Access Pharma: A Smallcap Cancer Biotech Call Option Trade [View article]
Dear Mike, This was an outstanding article and investors should always consider reviewing all your article before investing large amounts of their money. You give an edge to many, who do not have the time to research, or are just unware of the wonderful things going on with certain companies. Once again, a special 'THANK YOU' MIKE HAVRILLA. One last thing, much of what you stated above is so significant, compared to high burn rate, low priced stocks like for example 'MRNA'. Although they have a RNAI platform now, with their debt and no sales, they are totally dependant on just partnering. Leaving shareholders on the sidelines for the next 5-8 years, before anything is ever approved. Not a wise investment right now I should say, since they are a Pre-clinical stage company, correct?
Access Pharma: A Smallcap Cancer Biotech Call Option Trade [View article]
One last thing, much of what you stated above
is so significant, compared to high burn rate, low priced stocks like for example 'MRNA'. Although they have a RNAI platform now, with their debt and no sales, they are totally dependant on just partnering. Leaving shareholders on the sidelines for the next 5-8 years, before anything is ever approved. Not a wise investment right now I should say, since they are a Pre-clinical stage company, correct?